Impact of Pharmacists’ audit on improving the quality of prescription of dabigatran etexilate methanesulfonate: a retrospective study

[1]  M. Biteker,et al.  PRescriptiOn PattERns of Oral Anticoagulants in Nonvalvular Atrial Fibrillation (PROPER study) , 2017, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[2]  P. Giguère,et al.  Appropriateness of Dabigatran and Rivaroxaban Prescribing for Hospital Inpatients. , 2016, The Canadian journal of hospital pharmacy.

[3]  E. Hawes,et al.  Evaluation of prescribing and patient use of target‐specific oral anticoagulants in the outpatient setting , 2015, Journal of clinical pharmacy and therapeutics.

[4]  G. Caughey,et al.  An international comparison of spontaneous adverse event reports and potentially inappropriate medicine use associated with dabigatran , 2015, Pharmacoepidemiology and drug safety.

[5]  A. Armbruster,et al.  Evaluation of dabigatran for appropriateness of use and bleeding events in a community hospital setting. , 2014, American health & drug benefits.

[6]  Lauren A. Kimmons,et al.  Dabigatran Use in the Real World , 2014, Journal of pharmacy practice.

[7]  J. Dogné,et al.  Appropriateness of Prescribing Dabigatran Etexilate and Rivaroxaban in Patients With Nonvalvular Atrial Fibrillation , 2014, The Annals of pharmacotherapy.

[8]  D. Bates,et al.  Adverse drug events and medication errors in Japanese paediatric inpatients: a retrospective cohort study , 2014, BMJ quality & safety.

[9]  P. Bemt,et al.  Detection and correct handling of prescribing errors in Dutch hospital pharmacies using test patients , 2013, International Journal of Clinical Pharmacy.

[10]  D. Touchette,et al.  Drug Errors and Related Interventions Reported by United States Clinical Pharmacists: The American College of Clinical Pharmacy Practice‐Based Research Network Medication Error Detection, Amelioration and Prevention Study , 2013, Pharmacotherapy.

[11]  M. Sanjurjo-Sáez,et al.  Prescribing errors intercepted by clinical pharmacists in paediatrics and obstetrics in a tertiary hospital in Spain , 2012, European Journal of Clinical Pharmacology.

[12]  Susanne M. Smorenburg,et al.  On-ward participation of a hospital pharmacist in a Dutch intensive care unit reduces prescribing errors and related patient harm: an intervention study , 2010, Critical care.

[13]  David W. Bates,et al.  Incidence of Adverse Drug Events and Medication Errors in Japan: the JADE Study , 2010, Journal of General Internal Medicine.

[14]  S. Yusuf,et al.  Dabigatran versus warfarin in patients with atrial fibrillation. , 2009, The New England journal of medicine.

[15]  Yasuhiko Tomino,et al.  Revised equations for estimated GFR from serum creatinine in Japan. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[16]  D. Bates,et al.  Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. , 1999, JAMA.

[17]  S. Laporte,et al.  [New oral anticoagulants in nonvalvular atrial fibrillation]. , 2013, Presse medicale.